Ocumension Therapeutics Temettü
Temettü kriter kontrolleri 0/6
Ocumension Therapeutics does not have a record of paying a dividend.
Anahtar bilgiler
n/a
Temettü verimi
0.07%
Geri Alım Getirisi
Toplam Hissedar Getirisi | 0.07% |
Gelecekteki Temettü Verimi | 0% |
Temettü Büyümesi | n/a |
Bir sonraki temettü ödeme tarihi | n/a |
Eski temettü tarihi | n/a |
Hisse başına temettü | n/a |
Ödeme oranı | n/a |
Son temettü güncellemeleri
Güncelleme yok
Recent updates
With Ocumension Therapeutics (HKG:1477) It Looks Like You'll Get What You Pay For
Sep 21Analysts Are Upgrading Ocumension Therapeutics (HKG:1477) After Its Latest Results
Aug 15We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Ocumension Therapeutics' (HKG:1477) CEO For Now
Jun 13Ocumension Therapeutics' (HKG:1477) P/S Still Appears To Be Reasonable
Apr 29Here's Why We're Not Too Worried About Ocumension Therapeutics' (HKG:1477) Cash Burn Situation
Mar 14Some Analysts Just Cut Their Ocumension Therapeutics (HKG:1477) Estimates
Aug 29We're Hopeful That Ocumension Therapeutics (HKG:1477) Will Use Its Cash Wisely
Jul 13Is Ocumension Therapeutics (HKG:1477) Trading At A 48% Discount?
Jun 02We're Not Very Worried About Ocumension Therapeutics' (HKG:1477) Cash Burn Rate
Jan 20We're Not Very Worried About Ocumension Therapeutics' (HKG:1477) Cash Burn Rate
Sep 27Could The Ocumension Therapeutics (HKG:1477) Ownership Structure Tell Us Something Useful?
Jan 23Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: Insufficient data to determine if 1477's dividends per share have been stable in the past.
Büyüyen Temettü: Insufficient data to determine if 1477's dividend payments have been increasing.
Piyasaya Karşı Temettü Getirisi
Ocumension Therapeutics Piyasaya Karşı Temettü Getirisi |
---|
Segment | Temettü Verimi |
---|---|
Şirket (1477) | n/a |
Pazarın Alt %25'i (HK) | 3.2% |
Pazarın En İyi %25'i (HK) | 7.9% |
Sektör Ortalaması (Pharmaceuticals) | 3.7% |
Analist tahmini (1477) (3 yıla kadar) | 0% |
Önemli Temettü: Unable to evaluate 1477's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Yüksek Temettü: Unable to evaluate 1477's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: Insufficient data to calculate 1477's payout ratio to determine if its dividend payments are covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as 1477 has not reported any payouts.